Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0 - 1
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.015
EC/CAS
236-671-3/13463-41-7
Name of the chemical
Pyrithione zinc
Concentration
<0.002
EC/CAS
247-761-7/26530-20-1
Name of the chemical
2-Octyl-2H-isothiazol-3-one
Concentration
<0.0015
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.0005
General Information
Version
6.0
Revision date
2022-02-23
Product name
CFS-SP WB 360673-17
1.2.1 Relevant identified uses
Industrial/Professional use spec
Emergency telephone
+41 44 251 51 51
Icons in SDS
Company Information
company name
Hilti (Schweiz) AG
e-mail address of the competent person responsible for the Safety Data Sheet
info@hilti.ch, chemicals.hse@hilti.com
GHS Information
Signal word
2_2_5_HAZARD_STATEMENTS H412 - Harmful to aquatic life with long lasting effects. Precautionary statements (CLP) P273 - Avoid release to the environment
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available 2.2. Label elements Labelling
Hazard statements
H412 - Harmful to aquatic life with long lasting effects. Precautionary statements (CLP) P273 - Avoid release to the environment
Supplemental label elements
EUH208 - Contains 2-octyl-2H-isothiazol-3-one, Mixture of 5-chloro-2-methylisothiazol- 3(2H)-one and 2-methylisothiazol-3(2H)-one, 1,2-Benzisothiazol-3(2H)-on. May produce an allergic reaction
2.3 Other hazards
Component Zinc borate (138265-88-0) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Titanium dioxide (13463-67-7) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 1,2-Benzisothiazol-3(2H)-on (2634-33-5) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII pyrithione zinc (13463-41-7) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 2-octyl-2H-isothiazol-3-one (26530-20-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one (55965-84-9) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Zinc borate(138265-88-0) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Titanium dioxide(13463-67-7) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 1,2-Benzisothiazol-3(2H)-on(2634-33-5) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 pyrithione zinc(13463-41-7) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2-octyl-2H-isothiazol-3-one(26530-20-1) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one (55965-84-9) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
